Literature DB >> 1154044

The adoption of new drugs by doctors practising in group and solo practice.

P M Williamson.   

Abstract

Mesh：

Substances：

Year:  1975        PMID： 1154044     DOI： 10.1016/0037-7856(75)90027-x

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN： 0037-7856            Impact factor:   4.634


× No keyword cloud information.
  11 in total

1.  Adopting immunization recommendations: a new dissemination model.

Authors:  G L Freed; D E Pathman; T R Konrad; V A Freeman; S J Clark
Journal:  Matern Child Health J       Date:  1998-12

Review 2.  Implementing guidelines in general practice care.

Authors:  R Grol
Journal:  Qual Health Care       Date:  1992-09

3.  Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters.

Authors:  Anthony R Cox; Christopher Anton; Sarah E McDowell; John F Marriott; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

4.  General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study.

Authors:  Torben Dybdahl; Morten Andersen; Jakob Kragstrup; Ivar Sønbø Kristiansen; Jens Søndergaard
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

5.  Change in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice.

Authors:  R J Taylor; C M Bond
Journal:  Br J Gen Pract       Date:  1991-06       Impact factor: 5.386

6.  In with the new: the determinants of prescribing innovation by general practitioners in Ireland.

Authors:  Jane Bourke; Stephen Roper
Journal:  Eur J Health Econ       Date:  2011-04-19

7.  Access to new medications to treat schizophrenia.

Authors:  Tami L Mark; Riad Dirani; Eric Slade; Patricia A Russo
Journal:  J Behav Health Serv Res       Date:  2002-02       Impact factor: 1.505

8.  Identifying Primary Care Physicians Continuing Education Needs by Examining Clinical Practices, Attitudes, and Barriers to Screening Across Multiple Cancers.

Authors:  Brenna Lynn; Alexandra Hatry; Chloe Burnett; Lisa Kan; Tunde Olatunbosun; Bob Bluman
Journal:  J Cancer Educ       Date:  2018-12       Impact factor: 2.037

9.  Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models.

Authors:  Wei-Hsuan Lo-Ciganic; Walid F Gellad; Haiden A Huskamp; Niteesh K Choudhry; Chung-Chou H Chang; Ruoxin Zhang; Bobby L Jones; Hasan Guclu; Seth Richards-Shubik; Julie M Donohue
Journal:  Med Care       Date:  2016-07       Impact factor: 2.983

Review 10.  Factors affecting the uptake of new medicines: a systematic literature review.

Authors:  Ágnes Lublóy
Journal:  BMC Health Serv Res       Date:  2014-10-20       Impact factor: 2.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.